Vimarsana
Biggest News Aggregation in the World

Page 3 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest - Vimarsana News

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest

TORONTO, ON / ACCESSWIRE / May 31, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to

Sakai Chemical Industry : NOTICE OF THE 129TH ORDINARY GENERAL MEETING OF SHAREHOLDERS [ - Vimarsana News

Sakai Chemical Industry : NOTICE OF THE 129TH ORDINARY GENERAL MEETING OF SHAREHOLDERS [

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the...

Acasti Pharma (NASDAQ:ACST) Stock Passes Below 200-Day Moving Average of $2.79 - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Stock Passes Below 200-Day Moving Average of $2.79

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.79 and traded as low as $2.63. Acasti Pharma shares last traded at $2.72, with a volume of 13,600 shares traded. Wall Street Analyst […]

FSD Pharma Inc.: FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication - Vimarsana News

FSD Pharma Inc.: FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication

TORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1 - Vimarsana News

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

-- Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's -- ...